Phase 1 High Grade Serous Ovarian Cancer Clinical Trials

4 recruitingPhase 1

What is a Phase 1 trial?

Phase 1 trials test a new treatment in a small group of people for the first time. The primary goal is to evaluate safety, determine a safe dosage range, and identify side effects. These studies typically enroll 20 to 80 participants.

Showing 1–4 of 4 trials

Recruiting

Phase 1

Study to Assess Adverse Events and Pharmacokinetics in Adult Participants With Non-Small Cell Lung Cancer, Head and Neck Squamous Cell Carcinoma and Other Solid Tumors, Receiving Intravenous Infusion of Azirkitug Alone or in Combination(s) With Budigalimab, Bevacizumab, or Telisotuzumab Adizutecan

Triple-Negative Breast CancerPancreatic CancerNon-small Cell Lung Cancer+4 more

AbbVie694 enrolled46 locationsNCT05005403

Recruiting

Phase 1Phase 2

Rinatabart Sesutecan (Rina-S, PRO1184, GEN1184) for Advanced Solid Tumors (GCT1184-01/ PRO1184-001)

Triple-Negative Breast CancerEndometrial CancerPrimary Peritoneal Carcinoma+12 more

Genmab884 enrolled66 locationsNCT05579366

Recruiting

Phase 1

A Study of IDE034 in Adult Participants With Locally Advanced/Metastatic Solid Tumors Types

Triple-Negative Breast CancerColorectal, CancerNon-small Cell Lung Cancer+5 more

IDEAYA Biosciences150 enrolled5 locationsNCT07503808

Recruiting

Phase 1

Investigating Idetrexed and Olaparib in Patients With Ovarian Cancer

High Grade Serous Ovarian Cancer

Institute of Cancer Research, United Kingdom33 enrolled3 locationsNCT06976892